Capillary electrophoretic analysis of whole blood samples for hemoglobin-based oxygen carriers without the use of immunoprecipitation

被引:6
|
作者
Harrison, Christopher R. [1 ]
Vydha, Srilatha [1 ]
机构
[1] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA
关键词
Antidoping; Blood; Capillary electrophoresis; Sample preparation; PHOSPHOLIPID-BILAYER COATINGS; DOPING ANALYSIS; HUMAN SERUM; TRANSFUSIONS; PROTEINS; MICROENCAPSULATION; CHROMATOGRAPHY; CONFIRMATION; SEPARATION; BOVINE;
D O I
10.1002/elps.201100506
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Hemoglobin-based oxygen carriers (HBOCs) are blood substitutes, synthesized by polymerizing hemoglobin, which are being developed and investigated as alternatives to blood for medical purposes. However, due to their ability to increase the oxygen carrying capacity when taken by healthy individuals, HBOCs have been used as a doping agent among endurance athletes and are included in the World Anti-Doping Agency's Prohibited List. To maintain the fairness of competitions and continue the battle against doping, it is essential to be able to detect HBOCs if present in an athlete's blood. To achieve this goal, it is necessary to differentiate HBOCs from the native hemoglobin and to do so in a cost and time effective manner. We have developed a rapid capillary zone electrophoresis (CZE), UV absorbance, method capable of detecting HBOCs, in whole blood samples, at levels below those considered necessary to provide a performance enhancement. Our approach to the analysis for HBOCs utilizes the whole blood sample, not just the plasma, and does not require the use of immunoprecipitants to ensure accurate analysis. By lysing the red blood cells and using centrifugal filtration, followed by our CZE separation, we are able to effectively distinguish between native hemoglobin and HBOCs. Through this method, we have been able to reliably detect concentrations of HBOCs at the equivalent of 5.5 g/L, the equivalent to a 3.5% increase in blood hemoglobin concentration for an athlete.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 50 条
  • [41] Hemoglobin-Based Oxygen Carriers: Where Are We Now in 2023?
    Chen, Lin
    Yang, Zeyong
    Liu, Henry
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [42] INCREASED VASCULAR-RESISTANCE WITH HEMOGLOBIN-BASED OXYGEN CARRIERS
    HESS, JR
    MACDONALD, VW
    GOMEZ, CS
    COPPES, V
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (03): : 361 - 372
  • [43] POINTS TO CONSIDER IN THE SAFETY EVALUATION OF HEMOGLOBIN-BASED OXYGEN CARRIERS
    FRATANTONI, JC
    TRANSFUSION, 1991, 31 (04) : 369 - 371
  • [44] Hemoglobin-based oxygen carriers: Biochemical, biophysical differences, and safety
    Jahr, Jonathan S.
    MacKinnon, Khrystia
    Baum, Victor C.
    Alayash, Abdu I.
    TRANSFUSION, 2025, 65 (02) : 386 - 396
  • [45] Hemoglobin-based Oxygen Carriers Current Status and Future Directions
    Silverman, Toby A.
    Weiskopf, Richard B.
    ANESTHESIOLOGY, 2009, 111 (05) : 946 - 963
  • [46] Will fixing the vasoactivity caused by hemoglobin-based oxygen carriers be enough?
    Cabrales, Pedro
    Tsai, Amy G.
    CRITICAL CARE MEDICINE, 2009, 37 (06) : 2125 - 2126
  • [47] Ligand reactivity and allosteric regulation of hemoglobin-based oxygen carriers
    Ronda, Luca
    Bruno, Stefano
    Abbruzzetti, Stefania
    Viappiani, Cristiano
    Bettati, Stefano
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (10): : 1365 - 1377
  • [48] Hemoglobin-based oxygen carriers: Effect on serologic pretransfusion testing
    Shirey, RS
    Lewin, M
    Ness, PM
    Harrison, CR
    Stocks, CJ
    Hides, GA
    Doubleday, MD
    Gould, SA
    TRANSFUSION, 2004, 44 (09) : 122A - 123A
  • [49] Pharmacokinetics and mechanisms of plasma removal of hemoglobin-based oxygen carriers
    Estep, Timothy N.
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2015, 43 (03) : 203 - 215